PSA DENSITY IS A STRONGER PROGNOSTIC FACTOR THAN PSA IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE

被引：0
|
作者：
Chao-Yu, H.
Martin, S.
Paolo, G.
Alberto, B.
Giansilvio, M.
Bertrand, T.
Hein, V
Steven, J.
机构：
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF [-2]PROPSA IN COMBINATION WITH PSA AND FREE PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS, FOR IDENTIFYING PATIENTS WITH AGGRESSIVE PROSTATE CANCER. A MULTI-CENTER PROSPECTIVE CLINICAL EVALUATION.
    Catalona, William J.
    Sanda, Martin G.
    Wei, John T.
    Klee, George G.
    Slawin, Kevin M.
    Marks, Leonard S.
    Bangma, Chris H.
    Chan, Daniel W.
    Sokoll, Lori J.
    Roberts, William L.
    van Schaik, Ron
    Broyles, Dennis L.
    Cruz, Amabelle B.
    Le, Brian V.
    Mizrahi, Isaac A.
    Shin, Sanghyuk S.
    Partin, Alan W.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E56 - E56
  • [32] The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0ng/mL
    Shen, P.
    Zhao, J.
    Sun, G.
    Chen, N.
    Zhang, X.
    Gui, H.
    Yang, Y.
    Liu, J.
    Shu, K.
    Wang, Z.
    Zeng, H.
    ANDROLOGY, 2017, 5 (03) : 548 - 555
  • [33] RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy
    Gewanter, RM
    Katz, AE
    Olsson, CA
    Benson, MC
    Singh, A
    Schiff, PB
    Ennis, RD
    UROLOGY, 2003, 61 (05) : 967 - 971
  • [34] PSA DENSITY PERFORMS BETTER IN CAUCASIAN MEN THAN IN AFRICAN AMERICAN MEN IN PREDICTING PROSTATE CANCER AND SIGNIFICANT CANCER ON PROSTATE BIOPSY
    Kelly, Emily
    Morgan, Kevin
    Connelly, Zachary
    Babaian, Kara
    JOURNAL OF UROLOGY, 2019, 201 (04): : E654 - E654
  • [35] Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
    Wang, Cheng
    Wang, Yue-Yang
    Wang, Shi-Yuan
    Ding, Ji-Xiang
    Ding, Mao
    Ruan, Yuan
    Wang, Xiao-Hai
    Jing, Yi-Feng
    Han, Bang-Min
    Xia, Shu-Jie
    Jiang, Chen-Yi
    Zhao, Fu-Jun
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (04) : 415 - +
  • [36] Tumor histology as prognostic factor in locally advanced cervical cancer in a reference center
    Cantu de Leon, D.
    Gallardo-Alvarado, L. N.
    Ramirez, R.
    Perez-Montiel, D.
    Salcedo-Hernandez, R. A.
    Barquet-Munoz, S. A.
    Perez Quintanilla, M.
    Rivera-Buendia, F.
    Del Real, S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 177 - 178
  • [37] ONCOLOGICAL OUTCOMES AND PROGNOSTIC FACTORS AFTER RADICAL PROSTATECTOMY IN T3A PROSTATE CANCER: A MULTI-CENTER EXPERIENCE
    Hsu, C. Y.
    Joniau, S.
    Spahn, M.
    Marchioro, G.
    Tombal, B.
    Gontero, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 218 - 218
  • [38] Is percentage of cancer volume to prostate volume a stronger prognostic factor than cancer volume for the outcomes of CT3A prostate cancer?
    Hsu, C. Y.
    Joniau, S.
    Oyen, R.
    Roskams, T.
    Van, Poppel H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 155 - 155
  • [39] Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
    Kim, Dae Il
    Song, Jae Mann
    Chung, Hyun Chul
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (03) : 149 - 153
  • [40] The prognostic role of PSA Density in the detection of prostate cancer in men with PSA 4-10 ng/ml and negative both digital rectal examination and transrectal ultrasound
    Simaioforidis, V.
    Mitsios, K.
    Doumanis, G.
    Kontos, S.
    Komninos, C.
    Karavitakis, M.
    Koritsiadis, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 616 - 616
12345